Home › Funds › DOCK STREET ASSET MANAGEMENT INC › ABT

DOCK STREET ASSET MANAGEMENT INC position in ABT

ABBOTT LABORATORIES · Health Care

DOCK STREET ASSET MANAGEMENT INC reported holding 10,216 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.08% of its reported portfolio and ranking #42 among its reported holdings. DOCK STREET ASSET MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.22K sh
Reported value held$1.01M
Portfolio Weight0.08%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DOCK STREET ASSET MANAGEMENT INC's ABT position evolved

DOCK STREET ASSET MANAGEMENT INC first disclosed a stake in ABT in Q3 2023 at 14,615 shares (US$1.4M). The position peaked in Q4 2023 at 14,583 shares, worth US$1.6M. Across 13 filings, DOCK STREET ASSET MANAGEMENT INC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 10,216 shares valued at US$1.0M — an increase of 6,133 shares quarter over quarter.. Notable position changes include a 61% trim in Q2 2024 (shares rose 10% over the following quarter), a 123% increase in Q1 2025 (shares rose 3% over the following quarter), a 150% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.62K $1.42M New
Q4 2023 14.58K $1.61M Hold
Q1 2024 11.03K $1.25M Reduce
Q2 2024 4.28K $444.53K Reduce
Q3 2024 4.28K $487.74K Hold
Q4 2024 4.19K $474.04K Reduce
Q1 2025 9.34K $1.24M Add
Q2 2025 7.57K $1.03M Reduce
Q3 2025 7.24K $969.06K Reduce
Q4 2025 3.06K $383.01K Reduce
Q1 2026 4.08K $419.20K Add
Q2 2026 4.08K $370.49K Hold
Q3 2026 10.22K $1.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has DOCK STREET ASSET MANAGEMENT INC held ABT?

DOCK STREET ASSET MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DOCK STREET ASSET MANAGEMENT INC's current position in ABT?

As of Q3 2026, DOCK STREET ASSET MANAGEMENT INC holds 10.22K shares of ABT (ABBOTT LABORATORIES), valued at $1.01M, representing 0.08% of its reported portfolio and ranking #42.

Has DOCK STREET ASSET MANAGEMENT INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), DOCK STREET ASSET MANAGEMENT INC increased its position in ABT. The position peaked in Q4 2023 at 14.58K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.